Hépato-Gastro & Oncologie Digestive


Clinical research and protocols of the ANGH Volume 28, supplement 7, December 2021

1 Président du Conseil scientifique de l’ANGH
2 GHT Confluences, Centre Hospitalier Intercommunal Lucie et Raymond Aubrac, Service d’hépato-gastro-entérologie, Villeneuve-Saint-Georges
* Correspondance

Once again this year, ANGH was the initiator and partner of several clinical studies. Four studies published in international journals on the management of digestive bleeding. A study published on the management of primary cholangitis.

A forthcoming publication concerns a multicentre observatory evaluating the value of prescribing baclofen for alcohol dependence in 202 patients. Good practice recommendations concerning hydrothorax are being drafted. Various surveys concern hepatitis B/delta, screening for hepatocellular carcinoma in chronic HBV patients and the indication for and accessibility of TIPS. A large multicentre study to follow a cohort of chronically inactive HBV patients for 5 years has just been completed. An ongoing study aims to assess the impact of the Covid-19 crisis on the diagnosis and management of colorectal cancer. A patient questionnaire aims to assess the impact of physical activity on the quality of life of patients followed for IBD. A multicentre study aims to follow a cohort of patients diagnosed with NASH in the year preceding their inclusion. A practice survey on the modalities of ascites puncture in CHG aims to better understand the medical and paramedical modalities of this procedure. A study will organise systematic screening for the three viruses HBV/HCV/HIV in the population > 40 years old hospitalised for digestive endoscopy under general anaesthesia. A future study will look at certain aspects of the management of acute biliary pancreatitis, such as the type of enteral or traditional oral renutrition and the place of sphincterotomy.